Aim. Though combination of clopidogrel added to aspirin has been compared to aspirin
alone in patients with stroke or transient ischemic attack, limited data exists on the relative …

Objective: Patients experiencing acute ischemic stroke or transient ischemic attack are
commonly treated with clopidogrel and/or aspirin (mono-and dual-antiplatelet therapy) to …

Objective There is insufficient evidence on which to base a recommendation for optimal
antiplatelet therapy following a stroke while on aspirin. The objective was to compare …

Background and Purpose—We assessed the efficacy and safety of antiplatelet agents after
noncardioembolic stroke or transient ischemic attack and examined how these vary …

Recurrent stroke is common immediately following a transient ischemic attack (TIA) or
ischemic stroke. Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin may provide …

Background Clopidogrel was thought to be superior to aspirin for secondary prevention of
vascular diseases in clinical trials. In this study we assessed the safety and efficacy of …

Background The aim of this study was to analyze the benefits and safety associated with the
combination therapy of clopidogrel and aspirin among minor stroke or transient ischemic …

Background and Purpose—In patients with acute ischemic stroke caused by large artery
atherosclerosis, clopidogrel plus aspirin versus aspirin alone might be more effective to …

Background Combination antiplatelet therapy with clopidogrel and aspirin may reduce the
rate of recurrent stroke during the first 3 months after a minor ischemic stroke or transient …

Background: In patients with acute minor ischemic stroke or high-risk transient ischemic
attack enrolled in the POINT trial (Platelet-Oriented Inhibition in New TIA and Minor Ischemic …